¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"activated glycol aldehyde"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycol
    ±Û¸®ÄÝ
  • aldehyde
    ¾Ëµ¥È÷µå
  • aldehyde reductase
    ¾Ëµ¥È÷µåȯ¿øÈ¿¼Ò
  • activated adsorption
    Ȱ¼ºÈ­ÈíÂø
  • activated charcoal
    Ȱ¼º½¡, Ȱ¼ºÅº
  • activated coagulation time
    Ȱ¼ºÇ÷¾×ÀÀ°í½Ã°£
  • activated complex
    Ȱ¼ºÈ­º¹ÇÕ, Ȱ¼ºÈ­º¹ÇÕ¹°
  • activated partial thromboplastin time
    Ȱ¼ºÈ­ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • activated sludge method
    Ȱ¼ºÇذ¨¸ð·¡¹ý, Ȱ¼º¿À´Ï¹ý
  • activated sludge tank
    Ȱ¼ºÇذ¨¸ð·¡Åë, Ȱ¼º¿À´ÏÁ¶
  • fluorescence activated cell sorter
    Çü±¤Ç¥Áö¼¼Æ÷ºÐ·ù±â
  • lymphokine-activated killer cell
    ¸²Æ÷Ä«ÀÎȰ¼º»ìÇØ¼¼Æ÷
  • mitogen-activated protein kinase
    ¹ÌÅä°ÕȰ¼ºÈ­´Ü¹éÁúŰ³ª¾ÆÁ¦
  • magnetically activated implant
    ÀÚ±âȰ¼ºÀÌ½ÄÆí, ÀÚ±âȰ¼ºÈ­ÀÓÇÁ¶õÆ®
  • voice-activated control
    À½¼ºÀÛµ¿Á¶Àý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aldehyde
    ¾Ëµ¥È÷µå
  • glycol
    ±Û¸®ÄÝ
  • activated charcoal
    Ȱ¼º½¡, Ȱ¼ºÅº
  • activated partial thromboplastin time
    Ȱ¼ºÈ­ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aldehyde
    ¾Ëµ¥È÷µå
  • glycol
    ±Û¸®ÄÝ
  • activated charcoal
    Ȱ¼º½¡, Ȱ¼ºÅº
  • activated complex
    Ȱ¼ºº¹ÇÕ, Ȱ¼ºº¹ÇÕ¹°
  • activated adsorption
    Ȱ¼ºÈíÂø, Ȱ¼ºÈ­ÈíÂø
  • activated coagulation time
    Ȱ¼ºÇ÷¾×ÀÀ°í½Ã°£
  • activated partial thromboplastin time
    Ȱ¼ºÈ­ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • activated sludge method
    Ȱ¼ºÇذ¨¸ð·¡¹ý, Ȱ¼º¿À´Ï¹ý
  • activated sludge tank
    Ȱ¼ºÇذ¨¸ð·¡ÅÊÅ©, Ȱ¼º¿À´ÏÁ¶
  • lymphokine-activated killer cell
    ¸²Æ÷Ä«ÀÎȰ¼º¼¼Æ÷µ¶¼º¼¼Æ÷
  • voice-activated control
    À½¼ºÀÛµ¿Á¶Àý
  • fluorescence activated cell sorter
    Çü±¤Ç¥Áö¼¼Æ÷ºÐ¸®±â
  • magnetically activated implant
    ÀÚ±âȰ¼ºÀÌ½ÄÆí
  • mitogen-activated protein kinase
    ºÐ¿­Á¦È°¼º´Ü¹éŰ³ª¾ÆÁ¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyruvic aldehyde
    ÇÇ·çºó¾Ëµ¥È÷µå.
  • polyethylene glycol test =PEG test
    Æú¸®¿¡Æ¿·»±Û¸®Äݰ˻ç
  • polyethylene glycol=PEG
    Æú¸®¿¡Æ¿·»±Û¸®ÄÝ
  • Charcoal activated
    Ȱ¼ºÅº
  • Factor X activated
    Ȱ¼ºÈ­(üÀàõûù)µÈ X ÀÀ°íÀÎÀÚ(ëêͳì×í­)
  • activated
    Ȱ¼ºÈ­µÈ
  • activated adsorption
    Ȱ¼ºÈ­ÈíÂø(üÀàõûùýåó·).
  • activated charcoal
    Ȱ¼ºÅº.
  • activated clotting time
    Ȱ¼ºÈ­ÀÀ°í½Ã°£
  • activated coagulation time(ACT)
    Ȱ¼º Ç÷¾× ÀÀ°í½Ã°£
  • activated coagulation time=ACT
    Ȱ¼ºÈ­ ÀÀ°í½Ã°£
  • activated complex
    Ȱ¼ºº¹ÇÕ, Ȱ¼ºº¹ÇÕ¹°
  • activated macrophage
    Ȱ¼º´ë½Ä¼¼Æ÷, Ȱ¼º°Å½Ä¼¼Æ÷
  • activated molecule
    Ȱ¼ºÈ­ºÐÀÚ.
  • activated partial prothrombin time
    Ȱ¼º ºÎºÐÇÁ·ÎÆ®·Òºó½Ã°£
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aldehyde
    ¾Ëµ¥ÇÏÀ̵å.
  • aldehyde adduct
    ¾Ëµ¥È÷µåºÎ°¡¹°
  • pyruvic aldehyde
    ÇÇ·çºó¾Ëµ¥È÷µå.
  • ethylene glycol poisoning
    ¿¡Æ¿·» ±Û¸®ÄÝ Áßµ¶.
  • ethylene glycol poisoning
    ¿¡Æ¿·»±Û¸®ÄÝÁßµ¶
  • polyethylene glycol test =PEG test
    Æú¸®¿¡Æ¿·»±Û¸®Äݰ˻ç
  • polyethylene glycol=PEG
    Æú¸®¿¡Æ¿·»±Û¸®ÄÝ
  • triethylene glycol
    Æ®¸®¿¡Æ¿·»±Û¸®ÄÝ.
  • activated
    Ȱ¼ºÈ­µÈ
  • activated adsorption
    Ȱ¼ºÈ­ÈíÂø(üÀàõûùýåó·).
  • activated charcoal
    Ȱ¼ºÅº.
  • activated clotting time
    Ȱ¼ºÈ­ÀÀ°í½Ã°£
  • activated coagulation time(ACT)
    Ȱ¼º Ç÷¾× ÀÀ°í½Ã°£
  • activated coagulation time=ACT
    Ȱ¼ºÈ­ ÀÀ°í½Ã°£
  • activated complex
    Ȱ¼ºº¹ÇÕ, Ȱ¼ºº¹ÇÕ¹°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • butylene glycol fermentation
    ºÎÆ¿·»±Û¶óÀÌÄݹßÈ¿(Û£ý£)
  • glycol
    ±Û¶óÀÌÄÝ
  • polyethylene glycol
    Æú¸®¿¡Æ¿·» ±Û¶óÀÌÄÝ
  • active aldehyde
    Ȱ¼º(üÀàõ)¾Ëµ¥ÇÏÀ̵å
  • active aldehyde theory
    Ȱ¼º(üÀàõ)¾Ëµ¥ÇÏÀ̵å·Ð(Öå)
  • aldehyde
    ¾Ëµ¥ÇÏÀ̵å
  • aldehyde group
    ¾Ëµ¥ÇÏÀ̵å±â(Ðñ)
  • aldehyde indicator
    ¾Ëµ¥ÇÏÀ̵åÁö½Ã¾à(ò¦ãÆå·)
  • vitamin A1 aldehyde
    ºñŸ¹Î A1 ¾Ëµ¥ÇÏÀ̵å
  • activated alumina
    Ȱ¼º(üÀàõ)¾Ë·ç¹Ì³ª
  • activated complex
    Ȱ¼ºº¹ÇÕ¹° (üÀàõÜÜùêÚª)
  • activated form
    Ȱ¼ºÈ­Çü (üÀàõûùû¡)
  • calcium-activated factor
    Ä®½·ºÎȰ ÀÎÀÚ(Ý·üÀì×í­)
  • calcium-activated neutral proteinase
    Ä®½·ºÎȰ(Ý·üÀ) Áß¼º(ñéàõ)ÇÁ·ÎƼ³×À̽º
  • citrate-activated thrombin
    ½ÃÆ®¸£»êȰ¼º(ß«üÀàõ) Æ®·Òºó
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aldehyde
    ¾Ëµ¥È÷µå
  • magnetically activated implant
    ÀÚ±âȰ¼ºÀÌ½ÄÆí
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MAP malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ...
ADH   1) Aldehyde De-Hydrogenase
    = ALDH
  2) Anti-Diur...
ALDH ALdehyde DeHydrogenase
  = ADH
AF abnormal frequency; acid-fast; adult female; afebrile; aflatoxin; albumin-free; albumose-free; aldeh...
ALDH aldehyde dehydrogenase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AF Aldehyde Fuchsin
ALDH Aldehyde dehydrogenase
ALDH1 Aldehyde dehydrogenase
AldDH Aldehyde dehydrogenase
ALDH1 Aldehyde dehydrogenase 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • basic fuchsin-propylene glycol
    ¿°±â¼º Ç«½ÅÇÁ·ÎÇÊ·» ±Û¸®ÄÝ
  • polyethylene glycol test
    Æú¸® ¿¡Æ¿·» ±Û¸®ÄÝ °Ë»ç
  • aldehyde
    ¾Ëµ¥È÷µå
    -CHO±â¸¦ ź¼Ò»ç½½ ³¡¿¡ ÇÔÀ¯ÇÏ´Â À¯±â È­ÇÕ¹°±º.
  • aldehyde dehydrogenase(NAD+)
    ¾Ëµ¥ÇÏÀÌµå µðÇÏÀ̵å·ÎÁö³×À̽º
    acid anion + NADH = aldehyde + NAD + H2O ÀÇ È­ÇйÝÀÀÀ» Ã˸ÅÇÏ´Â »êÈ­ ȯ¿ø È¿¼Ò ÁßÀÇ Çϳª.
  • aldehyde-lyase
    ¾Ëµ¥ÇÏÀÌµå ¶óÀÌ¿¡À̽º
    ¾Ëµ¥ÇÏÀ̵å±âÀÇ Á¦°Å¸¦ Ã˸ÅÇÏ´Â ¶óÀÌ¿¡À̽º±º. ¿¹¸¦ µé¸é 4-hydroxy-2-oxobutyrate·ÎºÎÅÍ ÆÄÀÌ·çºó»ê°ú Æ÷¸§ ¾Ëµ¥ÇÏÀ̵带 »ý¼ºÇϰųª ¶Ç´Â L-threonineÀ¸·ÎºÎÅÍ ±Û¶óÀ̽Űú ¾Æ¼¼Æ® ¾Ëµ¥ÇÏÀ̵带 »ý¼ºÇÏ´Â °Í. ¾Ëµ¹·¹À̽ºµµ Æ÷ÇԵȴÙ.
  • palmitic aldehyde
    ÆÈ¹Ìƽ ¾Ëµ¥È÷µå
    ÆÈ¹Ìƽ»ê¿¡¼­ »©³½ ¾Ëµ¥È÷µå.
  • activated coagulation time
    Ȱ¼º Ç÷¾× ÀÀ°í½Ã°£
  • activated macrophage
    Ȱ¼º ´ë½Ä¼¼Æ÷, Ȱ¼º °Å½Ä¼¼Æ÷
  • activated protein C resistance
    Ȱ¼ºÈ­ C ´Ü¹é ³»¼º
  • activated sludge method
    Ȱ¼º ¿À´Ï¹ý
  • light activated
    ±¤ ÁßÇÕ
  • magnetically activated implant
    ÀÚ±â Ȱ¼º ÀÌ½ÄÆí
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
glycol <chemistry> A thick, colourless liquid, C2H4(OH)2, of a sweetish taste, produced artificially from certain ethylene compounds. It is a diacid alcohol, intermediate between ordinary ethyl alcohol and glycerin.
Any one of the large class of diacid alcohols, of which glycol proper is the type.
Origin: Glycerin + -ol. See Glycerin.
Source: Websters Dictionary
(01 Mar 1998)
glycol ethers Chemicals such as ethylene glycol monomethyl ether and ethylene glycol monoethyl ether; they are teratogens which induce testicular atrophy in animals.
(05 Mar 2000)
monomethoxypolyethylene glycol-arginase <chemical> Monomethylethylene glycol and arginase are attached covalently
Pharmacological action: antineoplastic agent
Synonym: mm-peg-arginase
(26 Jun 1999)
monomethoxypolyethylene glycol-conjugated asparaginase <chemical> Used in patients with haematological malignancies
Synonym: peg(2)-asp, 2,4-bis(2-methoxypolyethyleneglycol)-6-chloro-s-triazine-conjugated l-asparaginase
(26 Jun 1999)
monomethoxypolyethylene glycol-superoxide dismutase <chemical>
Pharmacological action: free radical scavengers
Synonym: mpeg-sod
(26 Jun 1999)
polyethylene glycol <chemical> A hydrophilic polymer that interacts with cell membranes and promotes fusion of cells to produce viable hybrids. Often used in producing hybridomas.
(18 Nov 1997)
polyethylene glycol dehydrogenase <enzyme> Catalyses the first step in polyethylene glycol metabolism in bacteria
Registry number: EC 1.1.1.-
(26 Jun 1999)
polyethylene glycol-glutaminase-asparaginase <chemical> Covalent attachment of polyethylene glycol to nonessential amine groups of enzyme renders it nonimmunogenic for treatment of leukaemia (EC 3.5.1.-)
Pharmacological action: immunosuppressive agent
Chemical name: glutaminase-asparaginase
Synonym: polyethyleneglycol-l-glutaminase-l-asparaginase, peg-l-glutaminase-l-asparaginase
(26 Jun 1999)
polyethylene glycol-superoxide dismutase <chemical> A free radical scavenger
Pharmacological action: free radical scavengers
Synonym: peg-sod
(26 Jun 1999)
polyethylene glycol-uricase <chemical> Uricase covalently attached to polyethylene glycol, modifying 71% of amino groups and retaining 11% of activity without eliciting antibody response in mice or man; used for lowering serum uric acid
Synonym: peg-uricase, methoxypolyethylene glycol uricase
(26 Jun 1999)
propylene glycol <chemical> A clear, colourless, viscous liquid used as a humectant and solvent in pharmaceutical preparations.
Derivative of propylene glycol (1,2-propanediol). They are used as humectants and solvents in pharmaceutical preparations.
Pharmacological action: cryoprotective agents, solvents, vehicles.
(12 Dec 1998)
diethylene glycol An organic solvent chemically related to ethylene glycol. Upon metabolic conversion it becomes oxalic acid, which is toxic to the kidney. A sweet, viscous liquid that was used to make the infamous elixir of sulfanilamide that proved fatal to over 100 children in 1937, leading to the establishment of the FDA to monitor drug safety.
(05 Mar 2000)
triethylene glycol C6H14O4; 2,2'-Ethylenedioxybis(ethanol);used in the vapor state as an air-sterilizing agent; toxic to bacteria, fungi, and viruses in very low concentrations in air; variations in the humidity of the air limit the germicidal effectiveness.
(05 Mar 2000)
ethylene glycol <chemical> A common ingredient in anti-freeze, very toxic to the liver if ingested
(27 Sep 1997)
L-glycol dehydrogenase <enzyme> Catalyses NADPH linked reversible reduction of uncharged vicinal dicarbonyls and alpha-hydroxycarbonyls to l-(+)-glycols
Registry number: EC 1.1.1.185
Synonym: l-(+)-glycol-NADP oxidoreductase, alpha-dicarbonyl reductase, l-(+)-alpha-hydroxycarbonyl-NADP oxidoreductase
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activated
    Ȱ¼ºÈ­µÈ
  • aldehyde
    ¾Ëµ¥È÷µå
  • ethylene glycol
    (È­)¿¡Æ¿·» ±Û¸®ÄÝ(ºÎµ¿¾×À¸·Î ¾²ÀÓ)
  • glycol
    ±Û¸®ÄÝ(±Û¸®¼¿¸°°ú ¿¡Æ¿¾ËÄڿðúÀÇ Áß°£ ¹°Áú,ÀÚµ¿Â÷µ¿ ºÎµ¿¾×)
  • propylene glycol
    ÇÁ·ÎÇÊ·» ±Û¸®ÄÝ(ºÎµ¿Á¦,À±È°À¯¿ë)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á